Bispecific Antibody Elisa

Lab Reagents

Antibody Elisa Laboratories manufactures the bispecific antibody elisa reagents distributed by Genprice. The Bispecific Antibody Elisa reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact antibody elisa. Other Bispecific products are available in stock. Specificity: Bispecific Category: Antibody Group: Elisa

Elisa information

Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem Fab)

BSFAB-046-50ug 50μg
EUR 2868
Description: A bispecific antibody that is expressed as an anti-CD2 Fd region fused to an anti-EGFR Fd region. The two Fd regions are connected by a flexible linker. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.

Recombinant Anti-BCMA x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-020-100ug 100μg
EUR 4272
Description: A bispecific antibody that is expressed as an anti-BCMA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Multiple myeloma (MM) therapy.

Recombinant Anti-BCMA x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-020-50ug 50μg
EUR 2446.8
Description: A bispecific antibody that is expressed as an anti-BCMA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Multiple myeloma (MM) therapy.

Recombinant Anti-CD123 x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-030-100ug 100μg
EUR 4272
Description: A bispecific antibody that is expressed as an anti-CD123 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Acute myelogenous leukemia (AML); Chronic myelogenous leukemia (CML); Plasmacytoid leukemia therapy.

Recombinant Anti-CD123 x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-030-50ug 50μg
EUR 2446.8
Description: A bispecific antibody that is expressed as an anti-CD123 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Acute myelogenous leukemia (AML); Chronic myelogenous leukemia (CML); Plasmacytoid leukemia therapy.

Recombinant Anti-CD19 x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-041-100ug 100μg
EUR 4552.8
Description: A bispecific antibody that is expressed as an anti-CD19 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Leukemia therapy.

Recombinant Anti-CD19 x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-041-50ug 50μg
EUR 2587.2
Description: A bispecific antibody that is expressed as an anti-CD19 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Leukemia therapy.

Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem scFv)

BSFV-046-100ug 100μg
EUR 4272
Description: A bispecific antibody that is expressed as an anti-CD2 scFv fused with an anti-EGFR scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.

Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem scFv)

BSFV-046-50ug 50μg
EUR 2446.8
Description: A bispecific antibody that is expressed as an anti-CD2 scFv fused with an anti-EGFR scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.

Recombinant Anti-CD33 x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-066-100ug 100μg
EUR 4272
Description: A bispecific antibody that is expressed as an anti-CD33 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Acute myeloid leukemia (AML); Ulcerative Colitis (UC); Myelodysplastic syndromes (MDS); Gastric cancer therapy.

Recombinant Anti-CD33 x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-066-50ug 50μg
EUR 2446.8
Description: A bispecific antibody that is expressed as an anti-CD33 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Acute myeloid leukemia (AML); Ulcerative Colitis (UC); Myelodysplastic syndromes (MDS); Gastric cancer therapy.

Recombinant Anti-CD3 x Anti-CEA Bispecific Antibody (Tandem scFv)

BSFV-072-100ug 100μg
EUR 4272
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-CEA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Colorectal cancer (CRC); Breast cancer; Lung cancer; Gastric cancer therapy.

Recombinant Anti-CD3 x Anti-CEA Bispecific Antibody (Tandem scFv)

BSFV-072-50ug 50μg
EUR 2446.8
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-CEA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Colorectal cancer (CRC); Breast cancer; Lung cancer; Gastric cancer therapy.

Recombinant Anti-EGFR x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-077-100ug 100μg
EUR 4272
Description: A bispecific antibody that is expressed as an anti-EGFR scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.

Recombinant Anti-CTLA4 x Anti-PD1 Bispecific Antibody (IgG-scFv)

IGFV-146 200μg Ask for price
Description: A bispecific antibody that is expressed as a LC and an extended HC with scFv moiety linked to the C terminus. It is a symmetric bispecific and tetravalent molecule, 2+2 antigen-binding valency. This BsAb can bind two factors simultaneously and enhance immune response. It is designed for the research of Tumors therapy.

Recombinant Anti-IL17 x Anti-TNF Bispecific Antibody (IgG-scFv)

IGFV-175 200μg Ask for price
Description: A bispecific antibody that is designed to be expressed as a LC and an extended HC with scFv moiety linked to the C terminus. It is a symmetric bispecific and tetravalent molecule, 2+2 antigen-binding valency. This BsAb can block two proinflammatory cytokines simultaneously. It is designed for the research of Rheumatoid arthritis (RA); Plaque psoriasis therapy.

Recombinant Anti-PD1 x Anti-EGFR Bispecific Antibody (Fab-IgG)

FABIG-356 200μg Ask for price
Description: A bispecific antibody that is expressed as three chains, assembling in vivo and resulting in the construct of Fab-IgG (Tandem Fab-Fc). This BsAb is designed for the research of tumor therapy.